Description
The active metabolite of irinotecan that potently inhibits DNA topoisomerase I; more cytotoxic to HT-29 colon cancer cells (IC50 = 8.8 nM) compared to irinotecan (IC50 > 100 nM)
Formal name: 4,11-diethyl-4,9-dihydroxy-(4S)-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Synonyms: 7-ethyl-10-hydroxy-20(S)-Camptothecin|7-Ethyl-10-Hydroxycamptothecin|NK 012
Molecular weight: 392.4
CAS: 86639-52-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Topoisomerases||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair